Saudi Pharmaceutical Industries and Medical Appliances 미래 성장

Future 기준 확인 4/6

Saudi Pharmaceutical Industries and Medical Appliances (는) 각각 연간 33.5% 및 10.1% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 31.5% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.8% 로 예상됩니다.

주요 정보

33.5%

수익 성장률

31.5%

EPS 성장률

Pharmaceuticals 수익 성장	16.3%
매출 성장률	10.1%
향후 자기자본 수익률	11.8%
애널리스트 커버리지	Low
마지막 업데이트	03 Dec 2024

최근 미래 성장 업데이트

Recent updates

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Solid Earnings May Rest On Weak Foundations

Nov 24

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Sep 05

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Mar 21

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

Jun 26

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Mar 14

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Aug 02

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

May 19

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

May 12

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Feb 20

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 18

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Mar 30

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

Feb 23

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Jan 19

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

Dec 16

수익 및 매출 성장 예측

SASE:2070 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (SAR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	2,153	185	192	183	5
12/31/2025	1,958	145	146	163	5
12/31/2024	1,726	114	39	-73	2
9/30/2024	1,628	23	-266	-156	N/A
6/30/2024	1,562	-18	-60	78	N/A
3/31/2024	1,597	-40	35	152	N/A
12/31/2023	1,653	-20	-70	48	N/A
9/30/2023	1,686	-76	-30	52	N/A
6/30/2023	1,662	-78	-60	7	N/A
3/31/2023	1,564	-142	-213	-136	N/A
12/31/2022	1,422	-152	-178	-99	N/A
9/30/2022	1,425	-94	-195	-109	N/A
6/30/2022	1,379	-42	-229	-136	N/A
3/31/2022	1,394	38	-10	73	N/A
12/31/2021	1,460	30	9	87	N/A
9/30/2021	1,471	57	-102	18	N/A
6/30/2021	1,532	117	-145	-24	N/A
3/31/2021	1,534	110	-172	-23	N/A
12/31/2020	1,555	130	-165	10	N/A
9/30/2020	1,521	-114	44	278	N/A
6/30/2020	1,491	-153	241	505	N/A
3/31/2020	1,518	-365	-37	275	N/A
12/31/2019	1,487	-434	18	352	N/A
9/30/2019	1,743	-163	-164	138	N/A
6/30/2019	1,626	-204	-461	-165	N/A
3/31/2019	1,566	6	-271	10	N/A
12/31/2018	1,503	74	-355	-74	N/A
9/30/2018	1,313	66	-280	-42	N/A
6/30/2018	1,366	61	N/A	25	N/A
3/31/2018	1,375	85	N/A	103	N/A
12/31/2017	1,386	139	N/A	155	N/A
9/30/2017	1,315	274	N/A	205	N/A
6/30/2017	1,295	296	N/A	118	N/A
3/31/2017	1,329	289	N/A	-21	N/A
12/31/2016	1,259	277	N/A	-94	N/A
9/30/2016	1,448	124	N/A	-281	N/A
6/30/2016	1,499	149	N/A	-134	N/A
3/31/2016	1,595	347	N/A	-53	N/A
12/31/2015	1,705	357	N/A	-38	N/A
9/30/2015	1,604	457	N/A	115	N/A
6/30/2015	1,562	465	N/A	44	N/A
3/31/2015	1,500	325	N/A	12	N/A
12/31/2014	1,470	317	N/A	43	N/A
9/30/2014	1,424	283	N/A	-94	N/A
6/30/2014	1,381	279	N/A	-79	N/A
3/31/2014	1,351	295	N/A	79	N/A
12/31/2013	1,311	267	N/A	54	N/A

애널리스트 미래 성장 예측

수입 대 저축률: 2070 의 연간 예상 수익 증가율( 33.5% )이 saving rate( 14.7% 보다 높습니다. ).

수익 vs 시장: 2070 의 연간 수익( 33.5% ) SA 시장( 6% 보다 빠르게 성장할 것으로 예상됩니다. 6% 연간).

고성장 수익: 2070 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: 2070 의 수익(연간 10.1% ) SA 시장( -0.5% 보다 빠르게 성장할 것으로 예상됩니다. -0.5% 연간).

고성장 수익: 2070 의 수익(연간 10.1% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 2070 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.8 %).

성장 기업 발견

기업 분석 및 재무 데이터 현황

데이터	마지막 업데이트(UTC 시간)
기업 분석	2024/12/26 22:08
장 마감 주가	2024/12/26 00:00
수익	2024/09/30
연간 수익	2023/12/31

데이터 소스

기업 분석에 사용된 데이터는 S&P Global Market Intelligence LLC의 데이터입니다. 이 보고서를 생성하기 위해 분석 모델에 사용된 데이터는 다음과 같습니다. 데이터는 정규화되어 있으므로 소스가 제공되기까지 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
회사 재무	10년	손익 계산서 현금 흐름표 대차 대조표	SEC 양식 10-K SEC 양식 10-Q
애널리스트 컨센서스 추정치	+3년	재무 예측 애널리스트 목표가	애널리스트 연구 보고서 Blue Matrix
시장 가격	30년	주식 가격 배당금, 분할 및 액션	ICE 시장 데이터 SEC 양식 S-1
소유권	10년	최대 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
관리	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발 사항	10년	회사 공지 사항	SEC 양식 8-K

* 미국 증권의 경우, 미국 외 지역의 규제 양식 및 출처가 사용된 예입니다.

명시되지 않는 한 모든 재무 데이터는 1년을 기준으로 하지만 분기별로 업데이트됩니다. 이를 후행 12개월(TTM) 또는 최근 12개월(LTM) 데이터라고 합니다. 여기에서 자세히 알아보세요.

분석 모델 및 눈송이

이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 Github 페이지에서 확인할 수 있으며, 보고서 사용 방법에 대한 가이드와 튜토리얼도 유튜브에서 확인할 수 있습니다.

Simply 월스트리트 분석 모델을 설계하고 구축한 세계적인 수준의 팀에 대해 알아보세요.

산업 및 부문 메트릭

업계 및 섹션 지표는 Simply Wall St에서 6시간마다 계산되며, 자세한 내용은 확인할 수 있습니다.

애널리스트 출처

Saudi Pharmaceutical Industries and Medical Appliances Corporation 7 애널리스트 중 5 애널리스트가 보고서의 입력 자료로 사용된 매출 또는 수익 추정치를 제출했습니다. 애널리스트의 제출 자료는 하루 종일 업데이트됩니다.

분석가	교육기관
Abdullah Alawi	Aljazira Capital Company
Madhu Appissa	Al Rajhi Capital
Aleksandar Stojanovski	Deutsche Bank

Saudi Pharmaceutical Industries and Medical Appliances 미래 성장

Future 기준 확인 4/6

주요 정보

최근 미래 성장 업데이트

Consensus EPS estimates fall by 11%

Consensus EPS estimates increase by 15%

Price target decreased by 9.5% to ر.س33.33

Price target increased by 40% to ر.س37.83

Consensus EPS estimates fall by 39%

Price target decreased to ر.س34.50

Recent updates

Consensus EPS estimates fall by 11%

Consensus EPS estimates increase by 15%

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Solid Earnings May Rest On Weak Foundations

New minor risk - Earnings quality

Third quarter 2024 earnings released

Now 21% undervalued

Now 22% undervalued

Investors Still Aren't Entirely Convinced By Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Revenues Despite 27% Price Jump

Second quarter 2024 earnings released: EPS: ر.س0.28 (vs ر.س0.19 in 2Q 2023)

Price target decreased by 9.5% to ر.س33.33

First quarter 2024 earnings released: EPS: ر.س0.30 (vs ر.س0.46 in 1Q 2023)

Saudi Pharmaceutical Industries and Medical Appliances Corporation, Annual General Meeting, Jun 02, 2024

Full year 2023 earnings: EPS and revenues miss analyst expectations

Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing

Saudi Pharmaceutical Industries and Medical Appliances Corporation Appoints Jerome Cabannes as Chief Executive Officer

Saudi Pharmaceutical Industries and Medical Appliances Corporation (SASE:2070) acquired 15% stake in Dammam Pharmaceutical from Cooper Pharma for SAR 27 million.

Third quarter 2023 earnings released: ر.س0.32 loss per share (vs ر.س0.38 loss in 3Q 2022)

Now 25% undervalued

Price target increased by 40% to ر.س37.83

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?

First quarter 2023 earnings released: EPS: ر.س0.47 (vs ر.س0.29 in 1Q 2022)

Full year 2022 earnings: EPS and revenues miss analyst expectations

Now 23% undervalued

Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?

Less than half of directors are independent

Third quarter 2022 earnings released: ر.س0.38 loss per share (vs ر.س0.062 profit in 3Q 2021)

Saudi Pharmaceutical Industries and Medical Appliances Corporation(SASE:2070) dropped from FTSE All-World Index (USD)

Second quarter 2022 earnings released: ر.س0.43 loss per share (vs ر.س0.26 profit in 2Q 2021)

Consensus EPS estimates fall by 39%

Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price

Price target decreased to ر.س34.50

Saudi Pharmaceutical Industries and Medical Appliances Corporation Approves Cash Dividend, Payable on June 27, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60

Saudi Pharmaceutical Industries and Medical Appliances Corporation, Annual General Meeting, Jun 08, 2022

One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates

Price target increased to ر.س36.25

Less than half of directors are independent

Saudi Pharmaceutical Industries and Medical Appliances Corporation Announces Executive Changes

Full year 2021 earnings: EPS and revenues miss analyst expectations

Saudi Pharmaceutical Industries and Medical Appliances Corporation Approves Formation of the Audit Committee

A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)

Saudi Pharmaceutical Industries and Medical Appliances Corporation, Annual General Meeting, Feb 23, 2022

Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit

Third quarter 2021 earnings released: EPS ر.س0.06 (vs ر.س0.56 in 3Q 2020)

Second quarter 2021 earnings released: EPS ر.س0.24 (vs ر.س0.21 in 2Q 2020)

Investor sentiment improved over the past week

Upcoming dividend of ر.س1.00 per share

First quarter 2021 earnings released: EPS ر.س0.22 (vs ر.س0.38 in 1Q 2020)

Saudi Pharmaceutical Industries and Medical Appliances Corporation Proposes Dividend for the Year Ended December 31, 2020

Full year 2020 earnings released: EPS ر.س0.91 (vs ر.س3.63 loss in FY 2019)

Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?

Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?

What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition

Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?

New 90-day high: ر.س38.65

Third quarter 2020 earnings released: EPS ر.س0.52

An unknown buyer acquired a part of an equity portfolio of Saudi Pharmaceutical Industries and Medical Appliances Corp for approximately SAR 480 million.

New 90-day high - ر.س36.95

New 90-day high - ر.س32.50

Earnings released